Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Background: Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in the modern world due to increased morbidity and due to its clinical consequences. It is a chronic liver disease, histologically divided into non-alcoholic steatohepatitis (NAFL) with isolated steatosis to non-alcoholic...
Saved in:
Main Authors: | Magdalena Mazurek (Author), Edyta Białowąs (Author), Ewelina Dybała (Author), Iwona Cuber (Author), Artur Aghadi (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023) -
Irritable bowel syndrome - a literature review
by: Iwona Cuber, et al.
Published: (2023) -
Pain therapy in the pediatric population
by: Edyta Białowąs, et al.
Published: (2023) -
Erythropoietin as banned substance in professional sports: effects on maximal aerobic capacity, endurance and detection methods - a review
by: Artur Aghadi, et al.
Published: (2023) -
Dry eye syndrome - vicious circle mechanism of disease
by: Ewelina Dybała, et al.
Published: (2023)